MIR192 Gene

HGNC Family Non-coding RNAs
Name microRNA 192
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nmiR‐192 plays multifaceted roles in tumor biology, acting in many contexts as a mediator of p53‐dependent cell cycle arrest and apoptosis. For example, miR‐192 is induced by genotoxic stress to promote growth‐inhibitory signals and tumor suppression in colon cancer cells"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ", and its investigation in colon cancer has further underscored its involvement in modulating key cell cycle regulators."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " In colorectal cancer cell lines, miR‐192 (often coupled with its homolog miR‐215) down‐regulates thymidylate synthase and induces cell cycle arrest"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": ", whereas in gastric cancer, overexpression of miR‐192 correlates with increased cell growth and migration by modulating the levels of adhesion molecules."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": " In lung cancer models, elevated miR‐192 expression suppresses proliferation and initiates apoptosis via targeting of retinoblastoma 1"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": ", and in breast cancer cells, stimulation of miR‐192 by BMP‐6 enforces cell cycle arrest through repression of RB1"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "&."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " Furthermore, in metastatic colon cancer models, miR‐192 inversely correlates with aggressive phenotypes by lowering the expression of anti‐apoptotic and pro‐angiogenic targets such as Bcl‐2, Zeb2 and VEGFA"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": ", while studies in bladder cancer support its tumor suppressor function by inhibiting proliferation and fostering apoptosis"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "&."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": " In addition, miR‐192 overexpression in bladder cancer has been associated with reduced cyclin D1 and increased levels of cell cycle inhibitors."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its roles in classical neoplastic settings, miR‐192 is critically involved in the regulation of renal and metabolic disorders. In diabetic nephropathy, diminished miR‐192 expression in proximal tubular cells correlates with increased fibrosis and impaired kidney function"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": ", while altered levels in serum have been linked with systemic autoimmune disorders such as systemic lupus erythematosus."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "13"}]}, {"type": "t", "text": " Moreover, TGF‐β signaling appears to modulate miR‐192 expression in the kidney through p53 and hepatocyte nuclear factor–dependent mechanisms"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": ", and studies in pancreatic ductal adenocarcinoma (PDAC) have reported elevated serum miR‐192 that promotes tumor cell proliferation by repressing SIP1."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": " In hepatocellular as well as HCV‐associated disease, miR‐192 serves as a potential biomarker for progression from fibrosis to carcinoma"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "16"}]}, {"type": "t", "text": ", and in certain hepatocellular carcinoma (HCC) models, dysregulated miR‐192 may in fact promote metastatic behavior by influencing targets such as SEMA3A."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "17"}]}, {"type": "t", "text": " Other investigations in diabetic kidney disease have noted altered miR‐192 profiles"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "18"}]}, {"type": "t", "text": "&"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "19"}]}, {"type": "t", "text": ", and in PDAC, epigenetic silencing of miR‐192 is linked to enhanced invasion"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "20"}]}, {"type": "t", "text": ", while further patient studies in diabetic nephropathy continue to emphasize its diagnostic relevance."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "21"}]}, {"type": "t", "text": " In chronic lymphocytic leukemia, reduced miR‐192 has been associated with loss of cell cycle control"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "22"}]}, {"type": "t", "text": ", and in hypertensive models, higher kidney miR‐192‐5p expression appears protective by attenuating Na+/K+–ATPase activity through ATP1B1 targeting"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "23"}]}, {"type": "t", "text": "&."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "24"}]}, {"type": "t", "text": " Additionally, in rheumatoid arthritis, restoration of miR‐192 reduces synoviocyte proliferation and inflammation via direct repression of caveolin 1."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "25"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nEmerging evidence further implicates miR‐192 in the modulation of diverse pathological conditions. Its altered levels have been observed in investigations of leptomeningeal dissemination in pediatric brain tumors"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "26"}]}, {"type": "t", "text": ", as well as in non‐alcoholic fatty liver disease and related metabolic disorders"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "27"}]}, {"type": "t", "text": "&."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "28"}]}, {"type": "t", "text": " In hepatocellular carcinoma, reduced miR‐192‐5p within cancer stem cell populations correlates with enhanced stemness via derepression of PABPC4."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "29"}]}, {"type": "t", "text": " Moreover, circulating miR‐192 has been proposed as an early biomarker in acute ischemic stroke"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "30"}]}, {"type": "t", "text": ", while in asthma, down‐regulation of miR‐192‐5p contributes to airway smooth muscle proliferation by modulating MMP‐16 and ATG7."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "31"}]}, {"type": "t", "text": " In sepsis‐induced myocardial injury, the lncRNA KCNQ1OT1 regulates miR‐192‐5p to control cardiomyocyte apoptosis via the XIAP axis"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "32"}]}, {"type": "t", "text": ", and in diabetic retinopathy, mesenchymal stem cell–derived extracellular vesicles shuttle miR‐192 to dampen inflammation and angiogenesis through ITGA1 inhibition."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "33"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Sara A Georges, Matthew C Biery, Soo-Yeon Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-08-1846"}], "href": "https://doi.org/10.1158/0008-5472.CAN-08-1846"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19074876"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19074876"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Bo Song, Yuan Wang, Kenji Kudo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-192 Regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-08-1422"}], "href": "https://doi.org/10.1158/1078-0432.CCR-08-1422"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19088023"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19088023"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Valentina Boni, Nerea Bitarte, Ion Cristobal, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Ther (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1535-7163.MCT-10-0061"}], "href": "https://doi.org/10.1158/1535-7163.MCT-10-0061"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20647341"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20647341"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Z Jin, F M Selaru, Y Cheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2010.534"}], "href": "https://doi.org/10.1038/onc.2010.534"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21119604"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21119604"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Shipeng Feng, Shujie Cong, Xin Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nucleic Acids Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/nar/gkr232"}], "href": "https://doi.org/10.1093/nar/gkr232"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21511813"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21511813"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "M Odenthal, E Bollschweiler, P P Grimminger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA profiling in locally advanced esophageal cancer indicates a high potential of miR-192 in prediction of multimodality therapy response."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.28253"}], "href": "https://doi.org/10.1002/ijc.28253"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23649428"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23649428"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Fen Hu, Xiangzhi Meng, Qi Tong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "BMP-6 inhibits cell proliferation by targeting microRNA-192 in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbadis.2013.08.011"}], "href": "https://doi.org/10.1016/j.bbadis.2013.08.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24012720"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24012720"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "L Geng, A Chaudhuri, G Talmon, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-192 suppresses liver metastasis of colon cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2013.478"}], "href": "https://doi.org/10.1038/onc.2013.478"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24213572"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24213572"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Robert H Jenkins, Luke C Davies, Philip R Taylor, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-192 induces G2/M growth arrest in aristolochic acid nephropathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Pathol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ajpath.2013.12.028"}], "href": "https://doi.org/10.1016/j.ajpath.2013.12.028"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24508230"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24508230"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Y J Xu, Y Fan "}, {"type": "b", "children": [{"type": "t", "text": "MiR-215/192 participates in gastric cancer progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Transl Oncol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12094-014-1194-6"}], "href": "https://doi.org/10.1007/s12094-014-1194-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24981590"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24981590"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Yongchao Jin, Jiasun Lu, Jiling Wen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of growth of human bladder cancer by miR-192."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-014-3020-8"}], "href": "https://doi.org/10.1007/s13277-014-3020-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25566965"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25566965"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Aleksandra Krupa, Robert Jenkins, Dong Dong Luo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Am Soc Nephrol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1681/ASN.2009050530"}], "href": "https://doi.org/10.1681/ASN.2009050530"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20056746"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20056746"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "G Wang, L S Tam, E K M Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Serum and urinary free microRNA level in patients with systemic lupus erythematosus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Lupus (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/0961203310389841"}], "href": "https://doi.org/10.1177/0961203310389841"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21372198"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21372198"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Robert H Jenkins, John Martin, Aled O Phillips, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transforming growth factor β1 represses proximal tubular cell microRNA-192 expression through decreased hepatocyte nuclear factor DNA binding."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BJ20111861"}], "href": "https://doi.org/10.1042/BJ20111861"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22264233"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22264233"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Chenyan Zhao, Jing Zhang, Shuhui Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2013.2420"}], "href": "https://doi.org/10.3892/or.2013.2420"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23612862"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23612862"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Tarek K Motawi, Olfat G Shaker, Shohda A El-Maraghy, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0137706"}], "href": "https://doi.org/10.1371/journal.pone.0137706"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26352740"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26352740"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Li Yan-Chun, Yi Hong-Mei, Chen Zhi-Hong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-192-5p Promote the Proliferation and Metastasis of Hepatocellular Carcinoma Cell by Targeting SEMA3A."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Appl Immunohistochem Mol Morphol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/PAI.0000000000000296"}], "href": "https://doi.org/10.1097/PAI.0000000000000296"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26580097"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26580097"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Xiaoyu Ma, Canlu Lu, Chuan Lv, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Expression of miR-192 and Its Significance in Diabetic Nephropathy Patients with Different Urine Albumin Creatinine Ratio."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Diabetes Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2016/6789402"}], "href": "https://doi.org/10.1155/2016/6789402"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26881255"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26881255"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Yijie Jia, Meiping Guan, Zongji Zheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miRNAs in Urine Extracellular Vesicles as Predictors of Early-Stage Diabetic Nephropathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Diabetes Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2016/7932765"}], "href": "https://doi.org/10.1155/2016/7932765"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26942205"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26942205"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Sandeep K Botla, Soniya Savant, Pouria Jandaghi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Early Epigenetic Downregulation of microRNA-192 Expression Promotes Pancreatic Cancer Progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-15-0390"}], "href": "https://doi.org/10.1158/0008-5472.CAN-15-0390"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27216198"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27216198"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Hung-Yu Chien, Chang-Yi Chen, Yen-Hui Chiu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential microRNA Profiles Predict Diabetic Nephropathy Progression in Taiwan."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Med Sci (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/ijms.15548"}], "href": "https://doi.org/10.7150/ijms.15548"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27279796"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27279796"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "S Fathullahzadeh, H Mirzaei, M A Honardoost, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Gene Ther (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cgt.2016.34"}], "href": "https://doi.org/10.1038/cgt.2016.34"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27659777"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27659777"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Yan-Fang Zou, Dan Wen, Qian Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Urinary MicroRNA-30c-5p and MicroRNA-192-5p as potential biomarkers of ischemia-reperfusion-induced kidney injury."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Biol Med (Maywood) (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/1535370216685005"}], "href": "https://doi.org/10.1177/1535370216685005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28056546"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28056546"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Maria Angeles Baker, Feng Wang, Yong Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-192-5p in the Kidney Protects Against the Development of Hypertension."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hypertension (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/HYPERTENSIONAHA.118.11875"}], "href": "https://doi.org/10.1161/HYPERTENSIONAHA.118.11875"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30595117"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30595117"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Supin Li, Zhenmu Jin, Xiaobing Lu "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-192 suppresses cell proliferation and induces apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes by downregulating caveolin 1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biochem (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11010-017-3003-3"}], "href": "https://doi.org/10.1007/s11010-017-3003-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28321538"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28321538"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Seung Yeob Yang, Seung Ah Choi, Ji Yeoun Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-192 suppresses leptomeningeal dissemination of medulloblastoma by modulating cell proliferation and anchoring through the regulation of DHFR, integrins, and CD47."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.6227"}], "href": "https://doi.org/10.18632/oncotarget.6227"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26506238"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26506238"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Philip P Becker, Monika Rau, Johannes Schmitt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0142661"}], "href": "https://doi.org/10.1371/journal.pone.0142661"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26565986"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26565986"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Chang-Hai Liu, Javier Ampuero, Antonio Gil-Gómez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hepatol (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jhep.2018.08.008"}], "href": "https://doi.org/10.1016/j.jhep.2018.08.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30142428"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30142428"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Yuanzhuo Gu, Xiyang Wei, Yulin Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-192-5p Silencing by Genetic Aberrations Is a Key Event in Hepatocellular Carcinomas with Cancer Stem Cell Features."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-18-1675"}], "href": "https://doi.org/10.1158/0008-5472.CAN-18-1675"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30530815"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30530815"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Xin-Wei He, Yan-Hui Shi, Yi-Sheng Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased plasma levels of miR-124-3p, miR-125b-5p and miR-192-5p are associated with outcomes in acute ischaemic stroke patients receiving thrombolysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Atherosclerosis (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.atherosclerosis.2019.08.002"}], "href": "https://doi.org/10.1016/j.atherosclerosis.2019.08.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31450012"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31450012"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Lili Lou, Mengyuan Tian, Jingxia Chang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiRNA-192-5p attenuates airway remodeling and autophagy in asthma by targeting MMP-16 and ATG7."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2019.109692"}], "href": "https://doi.org/10.1016/j.biopha.2019.109692"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31918268"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31918268"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Fangyuan Sun, Weifang Yuan, Hao Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA KCNQ1OT1 attenuates sepsis-induced myocardial injury via regulating miR-192-5p/XIAP axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Biol Med (Maywood) (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/1535370220908041"}], "href": "https://doi.org/10.1177/1535370220908041"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32102564"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32102564"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Cao Gu, Hongjun Zhang, Yu Gao "}, {"type": "b", "children": [{"type": "t", "text": "Adipose mesenchymal stem cells-secreted extracellular vesicles containing microRNA-192 delays diabetic retinopathy by targeting ITGA1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.30213"}], "href": "https://doi.org/10.1002/jcp.30213"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33325098"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33325098"}]}]}]}
Synonyms MIRN192, MIRNA192, MIR-192
NCBI Gene ID 406967
API
Download Associations
Predicted Functions View MIR192's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR192's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR192's ARCHS4 Predicted Functions.

Functional Associations

MIR192 has 931 functional associations with biological entities spanning 5 categories (molecular profile, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 25 datasets.

Click the + buttons to view associations for MIR192 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR192 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR192 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of MIR192 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores cellular components co-occuring with MIR192 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR192 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
CTD Gene-Disease Associations diseases associated with MIR192 gene/protein from the curated CTD Gene-Disease Associations dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores diseases co-occuring with MIR192 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR192 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR192 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of MIR192 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with MIR192 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing MIR192 from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of MIR192 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of MIR192 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with MIR192 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of MIR192 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR192 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of MIR192 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by MIR192 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MiRTarBase microRNA Targets microRNAs targeting MIR192 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of MIR192 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MPO Gene-Phenotype Associations phenotypes of transgenic mice caused by MIR192 gene mutations from the MPO Gene-Phenotype Associations dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR192 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with MIR192 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
WikiPathways Pathways 2014 pathways involving MIR192 protein from the Wikipathways Pathways 2014 dataset.